| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |